Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 04/23/2026 | Q1 | $6.9B | -- | -- | $1.91 | -- |
| 02/10/2026 | Q4 | $7.7B | $8B | $1.74 | $1.83 | -$0.08 |
| 10/30/2025 | Q3 | $7.5B | $7.8B | $2.43 | $2.14 | $0.30 |
| 08/07/2025 | Q2 | $7B | $7.1B | $1.56 | $1.96 | -$0.39 |
| 04/24/2025 | Q1 | $6.8B | $6.6B | $1.04 | $1.78 | -$0.73 |
| 02/11/2025 | Q4 | $7.2B | $7.6B | $1.42 | $1.70 | -$0.28 |
| 11/06/2024 | Q3 | $7B | $7.5B | $1.00 | $1.55 | -$0.54 |
| 08/08/2024 | Q2 | $6.7B | $6.9B | $1.29 | $1.60 | -$0.31 |
| 04/25/2024 | Q1 | $6.3B | $6.7B | -$3.34 | -$1.52 | -$1.82 |
| 02/06/2024 | Q4 | $7.1B | $7.1B | $1.14 | $1.76 | -$0.62 |
| 11/07/2023 | Q3 | -- | $7B | $1.73 | -- | -- |
| 08/03/2023 | Q2 | -- | $6.6B | $0.83 | -- | -- |
| 04/27/2023 | Q1 | -- | $6.3B | $0.80 | -- | -- |
| 02/02/2023 | Q4 | -- | $7.3B | $1.30 | -- | -- |
| 10/27/2022 | Q3 | -- | $7B | $1.42 | -- | -- |
| 08/02/2022 | Q2 | -- | $6.2B | $0.91 | -- | -- |
| 04/28/2022 | Q1 | -- | $6.6B | $0.02 | -- | -- |
| 02/01/2022 | Q4 | -- | $7.2B | $0.30 | -- | -- |
| 10/28/2021 | Q3 | -- | $7.4B | $2.05 | -- | -- |
| 07/29/2021 | Q2 | -- | $6.2B | $1.21 | -- | -- |
| 04/29/2021 | Q1 | -- | $6.4B | $1.37 | -- | -- |
| 02/04/2021 | Q4 | -- | $7.4B | $1.23 | -- | -- |
| 10/28/2020 | Q3 | -- | $6.6B | $0.29 | -- | -- |
| 07/30/2020 | Q2 | -- | $5.1B | -$2.66 | -- | -- |
| 04/30/2020 | Q1 | -- | $5.5B | $1.22 | -- | -- |
| 02/04/2020 | Q4 | -- | $5.8B | $2.12 | -- | -- |
| 10/24/2019 | Q3 | -- | $5.6B | -$0.92 | -- | -- |
| 07/30/2019 | Q2 | -- | $5.6B | $1.47 | -- | -- |
| 05/02/2019 | Q1 | -- | $5.3B | $1.54 | -- | -- |
| 02/04/2019 | Q4 | -- | $5.8B | $0.00 | -- | -- |
| 10/25/2018 | Q3 | -- | $5.6B | $1.60 | -- | -- |
| 07/25/2018 | Q2 | -- | $5.7B | $1.39 | -- | -- |
| 05/01/2018 | Q1 | -- | $5.1B | $1.17 | -- | -- |
| 02/06/2018 | Q4 | -- | $6B | -$2.96 | -- | -- |
| 10/26/2017 | Q3 | -- | $6.5B | $2.06 | -- | -- |
| 07/26/2017 | Q2 | -- | $7.1B | $2.33 | -- | -- |
| 05/02/2017 | Q1 | -- | $6.5B | $2.05 | -- | -- |
| 02/07/2017 | Q4 | -- | $7.3B | $2.34 | -- | -- |
| 11/01/2016 | Q3 | -- | $7.5B | $2.49 | -- | -- |
| 07/25/2016 | Q2 | -- | $7.8B | $2.58 | -- | -- |
| 04/28/2016 | Q1 | -- | $7.7B | $2.53 | -- | -- |
Gilead Sciences, Inc. reported $8B worth of top line sales in its most recent quarter.
Gilead Sciences, Inc. announced earnings per share of $1.74 which represents a miss of analyst forecast a $1.83 per share.
Gilead Sciences, Inc. reported $6.3B that represents $5.06 per share over the last quarter.
Gilead Sciences, Inc.'s earnings are forecast to grow from $6.78 per share to $8.12 per share next year representing an increase of 28.01%.
Gilead Sciences, Inc.'s next earnings date is April 23, 2026.
Signup to receive the latest stock alerts
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Since January 28th, software stocks in the United States have…
Over the last five days, shares of Instagram and Facebook…
Market Cap: $4.4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 29x
Market Cap: $3.7T
P/E Ratio: 29x
MicroSectors Gold Miners -3X Inverse Leveraged ETN [GDXD] is up 19.01% over the past day.
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 18.95% over the past day.
Rocket Lab Corp. [RKLB] is up 1.53% over the past day.